Audiologists in Maple Grove, MN Accepting Medicare

6 Audiologists found. Showing 1 - 6

Dr. Katherine Lynn Awoyinka, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 9825 Hospital Drive, Suite Ll-10, Maple Grove, MN 55369 Phone: 612-339-2836

Ashley Waldock, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9825 Hospital Dr, Suite Ll-10, Maple Grove, MN 55369 Phone: 612-339-2836

Bethany Wysocki, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 9555 Upland Ln N, Maple Grove, MN 55369 Phone: 952-993-1440

Jka5 Maple Grove Inc Audiologist Medicare: Medicare Enrolled Practice Location: 7270 Forestview Ln N, 225, Maple Grove, MN 55369 Phone: 320-252-0094

Bridget Miskowiec Carlson, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9825 Hospital Dr, Suite Ll 10, Maple Grove, MN 55369 Phone: 612-339-2836

Alexis Jean Sherrick, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 9555 Upland Ln N, Maple Grove, MN 55369 Phone: 952-993-9900

News Archive

Better primary care needed to reduce unnecessary ED visits by Medicaid patients

Although a goal of Medicaid expansion under the Affordable Care Act was to provide Medicaid patients with a source of nonemergency care outside of hospital emergency departments (EDs), researchers suggest that these newly enrolled patients will likely continue to look to EDs for treatment of chronic diseases and other nonemergency issues, despite state attempts to impose fees on ED visits.

Liver's cannabinoid receptors could be targeted to combat liver cancer in some patients

A new study reveals that the liver's cannabinoid receptors could be targeted to fight liver cancer in some patients; and it offers a way to predict what treatments have the best chance of working.

Innovative nano-therapy treatment can fight chronic inflammatory disorders, cancer

For an innovative treatment, which allows to selectively direct nanoparticles of iron oxide into cell targets in the blood to fight chronic inflammatory disorders or cancer that was successfully tested in a cell culture and animal models, Dr. Andrea de Vizcaya Ruiz, was awarded with the Innovation Award in Bionanotechnology Cinvestav-Neolpharma 2015.

Antimalarials could disrupt SARS-CoV-2's Nsp1 translation termination

A research team from the Engelhardt Institute of Molecular Biology in Russia have shown that Nsp1 – a non-structured protein present in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pathogen – stimulates translation termination in the stop codon recognition stage. Studying and developing drugs that compete with Nsp1 for binding with the termination complex could therefore be a potential strategy for fighting against coronavirus disease 2019 (COVID-19).

Read more Medical News

› Verified 7 days ago